PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: stock market

Clinical study protocol template

Global Clinical Development - General Medicine QAW039/fevipiprantClinical Trial protocol CQAW039A2316 / NCT03215758A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthmaDocument type: Clinical Trial ProtocolEUDRACT number:2017-001273-16 Version number:00 (OriginalProtocol) Clinical trial phase:IIIR elease date:10- May-2017 Property of NovartisConfidentialMay not be used, divulged, published, or otherwise disclosedwithout the consent of NovartisClinical Trial protocol template Version (July 2016)NovartisConfidentialPage 2 Clinical Trial protocol (Version 00) protocol No.

Clinical Trial Protocol CQAW039A2316 / NCT03215758 A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with …

Fullscreen Download
Loading..

Tags:

  Clinical, Protocol, Trail, Clinical trial protocol

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Clinical study protocol template

Documents from same domain

Research Proposal - ClinicalTrials.gov

clinicaltrials.gov

as fecal microbiota transplantation (FMT). 4. Procedures Tissue samples will be obtained from consenting patients at (SDMCUT), or other relevant facilities (see section 6.i below), in accordance with protocols approved by the University of Texas Institutional Review Board (UTIRB). Patients who meet eligibility criteria will have their

  Research, Proposal, Fecal, Microbiota, Transplantation, Research proposals, Fecal microbiota transplantation

Statistical Analysis Plan (SAP) - ClinicalTrials.gov

clinicaltrials.gov

statistical analysis. The subsections below will describe analyses in addition to the descriptive statistics. 6.1 Primary outcome The primary analysis will compare intervention groups (water supplementation vs control treatment) on their mean change in fasting plasma glucose between baseline and 12 months using a linear mixed model.

  Analysis

A Phase II, Randomized, Double -blind, Placebo -controlled ...

clinicaltrials.gov

• International Conference on Harmonisation, E6 Good Clinical Practice: Consolidated Guideline. • All applicable laws and regulations, including, without limitation, data privacy laws and regulations. • Regulatory requirements for reporting serious …

  Good, Practices, Clinical, Good clinical practice

Clinical Study Report (CSR) Template (Drug and Device)

clinicaltrials.gov

ATC Anatomical Therapeutic Chemical CFB change from baseline DHA dapsone hydroxylamine eCRF electronic case report form IGA Investigator’s Global Assessment MedDRA Medication Dictionary for Regulatory Activities mITT modified intent-to-treat NAD N-acetyl dapsone PK pharmacokinetic ...

  Chemical, Therapeutic, Anatomical, Anatomical therapeutic chemical

New antibiotic treatment options for uncomplicated ...

clinicaltrials.gov

treatment options for gonorrhoea and only a few new drugs in the development pipeline, it is important to test existing antibiotics for their efficacy in gonorrhoea treatment. Objective : This project aims to identify new treatment modalities for uncomplicated gonorrhoea using

  Gonorrhoea

A PROSPECTIVE MULTI CENTER RANDOMIZED CONTROLLED …

clinicaltrials.gov

conjunction with Ceramic on Ceramic and Taperloc Complete Microplastyarticulation stem in primary total hip arthroplasty compared to patients who received the Exceed ABT Acetabular system with the same combination.

  System, Complete, Taperloc, Taperloc complete

Title: A Phase 1, Randomized, Double-Blind, Placebo ...

clinicaltrials.gov

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability and Pharmacokinetic Study of Escalating Single and Multiple Doses of TAK-653 in Healthy Subjects Phase 1 TAK-653 Escalating Single and Multiple Dose Study in Healthy Subjects Sponsor: Takeda Development Centre Europe Ltd. 61 Aldwych London, WC2B 4AE United Kingdom

  Controlled, Double, Blind, Placebo, Randomized, Double blind, Placebo controlled

Novartis CSR template

clinicaltrials.gov

9.1 Study design Figure 9-1 Study design BID: twice a day, QD: once a day. This was a multicenter, randomized, double-masked, two-arm, placebo-controlled, parallel-group study in patients with normal tension glaucoma who were insufficiently controlled on travoprost 0.004% (Travatan) monotherapy. Approximately 200 patients were planned to be

  Design, Study, Parallel, Study design

DETAILED STATISTICAL ANALYSIS PLAN (SAP)

clinicaltrials.gov

Statistical principles : 4.1. Multiplicity : The diagnostic and prognostic basic stud y and each sub -study consist of one primary outcome and one or more secondary, exploratory outcomes. We will encounter multiplicity issues due to the multiple

  Principles, Statistical, Statistical principles

Title: TWILIGHT Study - Ticagrelor With Aspirin or Alone ...

clinicaltrials.gov

Prior stroke Dialysis-dependent renal failure Active bleeding or extreme-risk for major bleeding (e.g. acute ... Life expectancy < 1 year ... 7.3.4 Adverse Events based on signs and symptoms ...

  Based, Life, Stroke, Life expectancy, Expectancy

Related documents

IS IT A CLINICAL TRIAL OF A MEDICINAL PRODUCT?

assets.publishing.service.gov.uk

advance by a clinical trial protocolviii? E.4 Is the decision to prescribe a particular medicinal product clearly separated from the decision to include the patient in the study? E.5 Will no diagnostic or monitoring procedures be applied to the patients included in the study, other

  Product, Clinical, Medicinal, Trail, Clinical trials, Clinical trial of a medicinal product

Writing the research protocol

icahn.mssm.edu

Writing the research protocol 5.1 Introduction After proper and complete planning of the study, the plan should be written down. ... • Women were often excluded from clinical trials on disease conditions that affect both men and women, on the basis of …

  Clinical, Protocol

Research Article Trends in Internal Medicine

newsrescue.com

clinical trial designs of the pivotal trials and the resulting data was ... the first dose according to protocol. Because of dropouts, adverse events were recorded on 15,185 vaccinated patients and 15,166 placebo patients (reference 5, appendix table S8). The treatment

  Clinical, Protocol, Trail, Clinical trials

Ventilator Protocol - NHLBI ARDS Network

www.ardsnet.org

B. SPONTANEOUS BREATHING TRIAL (SBT): If all above criteria are met and subject has been in the study for at least 12 hours, initiate a trial of UP TO 120 minutes of spontaneous breathing with FiO2 < 0.5 and PEEP < 5: 1. Place on T-piece, trach collar, or CPAP ≤ 5 cm H 2O with PS < 5 2. Assess for tolerance as below for up to two hours. a. SpO

  Protocol, Trail

Related search queries

CLINICAL TRIAL OF A MEDICINAL PRODUCT, Clinical trial, Protocol, Clinical, Trial